Diagnosis, Risk Factors, and Outcome of Urethral Recurrences Following Radical Cystectomy for Bladder Cancer in 729 Male Patients

European Urology

Volumn 53, Issue 4, 2008, Pages 785-793

  Huguet, Jorge ^a   Monllau, Vanesa ^a   Sabaté, Sergi ^a   Rodriguez Faba, Oscar ^a   Algaba, Ferran ^a   Palou, Juan ^a   Villavicencio, Humberto ^a  

^a FUNDACIÓ PUIGVERT   (Spain)

Author keywords

Cystectomy; Neoplasm recurrence; Transitional cell carcinoma; Urethra

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

AGED; CHI-SQUARE DISTRIBUTION; CYSTECTOMY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 39549083891     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.06.045     Document Type: Article

References (24)

1. Clark P.E., and Hall M.C. Contemporary management of the urethra in patients after radical cystectomy for bladder cancer. Urol Clin N Am 32 (2005) 199-206
2. Lin D.W., Herr H.W., and Dalbagni G. Value of urethral wash cytology in the retained male urethra after radical cystoprostatectomy. J Urol 169 (2003) 961-963
3. Clark P.E., Stein J.P., Groshen S.G., et al. The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer. J Urol 172 (2004) 1342-1347
4. Freeman J.A., Ersing D.E., Stein J.P., and Skinner D.G. Management of the patient with bladder cancer. Urethral recurrence. Urol Clin N Am 21 (1994) 645-651
5. Freeman J.A., Tarter T.A., Ersing D., et al. Urethral recurrence in patients with orthotopic ileal neobladders. J Urol 156 (1996) 1615-1619
6. Stein J.P., Clark P., Miranda G., Cai J., Groshen S., and Skinner D.G. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J Urol 173 (2005) 1163-1168
7. Hassan J.M., Cookson M.S., Smith J.A., and Chang S.S. Urethral recurrence in patients following orthotopic urinary diversion. J Urol 172 (2004) 1338-1341
8. Joniau S., Shabana W., Verlinde B., and Van Poppel H. Prepubic urethrectomy during radical cystoprostatectomy. Eur Urol 51 (2007) 915-921
9. Hautmann R., Volkmer B.G., Schumacher M.C., Gschwend J.E., and Studer U.E. Long-term results of standard procedures in urology: the ileal neobladder. World J Urol 24 (2006) 305
10. Lopez-Beltran A., Bassi P., Pavone-Macaluso M., and Montironi R. Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter and renal pelvis. Eur Urol 45 (2004) 257-266
11. Huguet J., Palou J., Serrallach M., Solé Balcells F.J., Salvador J., and Villavicencio H. Management of urethral recurrence in patients with Studer ileal neobladder. Eur Urol 43 (2003) 495-498
12. Stenzl A., Bartsch G., and Rogatsch H. The remnant urothelium after reconstructive bladder surgery. Eur Urol 41 (2002) 124-131
13. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol 51 (2007) 152-160
14. Nielsen M.E., Shariat S.F., Karakiewicz P.I., et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cistectomy. Eur Urol 51 (2007) 699-708
15. Hardeman S.W., and Soloway M.S. Urethral recurrence following radical cystectomy. J Urol 144 (1990) 666-669
16. Huguet J., Crego M., Sabaté S., Salvador J., Palou J., and Villavicencio H. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: precystectomy prostate involvement as a prognostic factor. Eur Urol 48 (2005) 53-59
17. Stockle M., Alken P., Engelmann U., Jacobi G.H., Riedmiller H., and Hohenfellner R. Radical cystectomy-often too late?. Eur Urol 13 (1987) 361-367
18. Yossepowitch O., Dalbagni G., Golijanin D., et al. Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. J Urol 169 (2003) 177-181
19. Arce J., Palou J., Gaya J.M., et al. Incidence and extent of prostatic urethral involvement in radical cystoprostatectomy specimens: the importance of previous bladder disease and carcinoma in situ of the bladder. Eur Urol Suppl 6 (2007) 26 (abstract no. 14)
20. Iselin H.E., Robertson C.N., Webster G.D., Vieweg J., and Paulson D.F. Does prostate transitional cell carcinoma preclude orthotopic bladder reconstruction after radical cystoprostatectomy for bladder cancer?. J Urol 158 (1997) 2123-2125
21. Chang S.S. Short and long-term issues regarding urethral management in male radical-cystectomy patients. Curr Opin Urol 15 (2005) 332-335
22. Balaji K.C., Mcguire M., Grotas J., Grimaldi G., and Russo P. Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation. J Urol 162 (1999) 1603-1606
23. Huguet-Perez J., Palou J., Millan-Rodriguez F., Salvador Bayarri J., Villavicencio-Mavrich H., and Vicente-Rodriguez J. Upper tract transitional cell carcinoma following cystectomy for bladder cancer. Eur Urol 40 (2001) 318-323
24. Lebret T., Herve J.M., Gaudez F., Lugagne P.M., Bargelatta M., and Botto H. Urethral recurrence of transitional cell carcinoma of the bladder. Eur Urol 33 (1998) 170-174